All lobbying filings

BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.)

Lobbying for BEONE MEDICINES USA, INC (FORMERLY BEIGENE USA, INC.)

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $230,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 1

Health Issues

Issues related to drug pricing, including federal proposals impacting reimbursement, access, and affordability; Issues related to Medicare Drug negotiation and implementation of the Inflation Reduction Act; ORPHAN Cures Act and pharmacy benefit manager reform legislation (H.R. 1, One Big Beautiful Bill Act); Issues related to Most Favored Nation (MFN) pricing models

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.